HMC
Honda Motor Co., Ltd.
HMC has lower modeled downside risk, despite its lower overall score.
NIO
NIO Inc.
NIO has a slight edge over HMC overall, supported by stronger fundamentals and stronger modeled upside.
HMC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Stable | |
| Strong |
HMC's revenue and balance sheet are currently healthy, and its cash flow is stable, but its profitability is under pressure.
NIO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Unavailable |
NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.
HMC PE Valuation
HMC has no meaningful PE right now: it lost money over the past year.
NIO PE Valuation
NIO has no meaningful PE right now: it lost money over the past year.
HMC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect HMC to return to profit, with revenue growing.
NIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect NIO's losses to shrink, with revenue growing.
HMC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.81 | -131% |
| Q1 2026 | -$2.11 | -164% |
| Q4 2025 | $2.25 | -45% |
| Q3 2025 | $2.75 | -28% |
| Q2 2025 | $2.63 | -40% |
| Q1 2025 | $3.29 | -22% |
| Q4 2024 | $4.08 | +14% |
| Q3 2024 | $3.83 | +9.4% |
HMC has swung to a loss: it lost $0.81 per share over the past year, after a profit the year before.
NIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.29 | +$1.45 |
| Q1 2026 | -$0.60 | +$1.16 |
| Q4 2025 | -$1.06 | +$0.60 |
| Q3 2025 | -$1.59 | +$0.02 |
| Q2 2025 | -$1.74 | -$0.10 |
| Q1 2025 | -$1.76 | +$0.06 |
| Q4 2024 | -$1.66 | +$0.21 |
| Q3 2024 | -$1.61 | +$0.32 |
NIO has the edge over HMC on earnings, with more consistent year-over-year improvement.
HMC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $38B | +14% |
| Q1 2026 | $36.5B | +8.6% |
| Q4 2025 | $33.5B | -3.4% |
| Q3 2025 | $33.2B | -1.9% |
| Q2 2025 | $33.5B | -1.2% |
| Q1 2025 | $33.6B | -1.3% |
| Q4 2024 | $34.7B | +2.6% |
| Q3 2024 | $33.8B | +8.2% |
HMC's revenue is growing: $38B last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 8.8% | +4.2 points |
| Q1 2026 | -17% | -19 points |
| Q4 2025 | 2.9% | -4.3 points |
| Q3 2025 | 3.7% | -15 points |
| Q2 2025 | 4.6% | -4.4 points |
| Q1 2025 | 1.4% | -4.3 points |
| Q4 2024 | 7.2% | +0.1 points |
| Q3 2024 | 19% | +13 points |
HMC has the edge over NIO on profitability, with a higher operating margin.
NIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +69% |
| Q1 2026 | $3.8B | +112% |
| Q4 2025 | $5.2B | +76% |
| Q3 2025 | $3.3B | +17% |
| Q2 2025 | $2.9B | +9% |
| Q1 2025 | $1.8B | +21% |
| Q4 2024 | $3B | +15% |
| Q3 2024 | $2.8B | -2.1% |
NIO has the edge over HMC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | +24 points |
| Q1 2026 | -1.2% | +52 points |
| Q4 2025 | 2.3% | +33 points |
| Q3 2025 | -16% | +12 points |
| Q2 2025 | -26% | +4 points |
| Q1 2025 | -53% | +1.1 points |
| Q4 2024 | -31% | +8.1 points |
| Q3 2024 | -28% | -2.6 points |
NIO's operating margin was −2.1% last quarter, up 24 points from the same quarter a year ago.
HMC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$2.2B | -$1.4B |
| Q1 2026 | $870.1M | +$1.8B |
| Q4 2025 | $612.2M | +$1.3B |
| Q3 2025 | $726.9M | +$772.3M |
| Q2 2025 | -$719.2M | $0 |
| Q1 2025 | -$942.2M | $0 |
| Q4 2024 | -$683.5M | $0 |
| Q3 2024 | -$45.5M | $0 |
HMC's free cash flow has turned positive after two years mostly in the red: $45M over the past year.
NIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$2.1B |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$391.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$2.1B | +$73.9M |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$391.3M | -386% |
| Q2 2024 | -$2.2B | +$337.9M |
NIO has the edge over HMC on cash flow, with more consistent year-over-year improvement.
HMC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.7% | +62.8M shares |
| 1 year | 0% | -42.7K shares |
| 3 years | -15% | -257M shares |
| 5 years | -19% | -326M shares |
| Available history | -20% | -359M shares |
HMC has the edge over NIO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | $576,658 |
| Q4 2025 | — |
| Q3 2025 | $1.9B |
| Q2 2025 | $2.3B |
| Q1 2025 | $2.7B |
| Q4 2024 | $423.3M |
| Q3 2024 | $1.3B |
HMC spent $1.9B buying back its own shares over the past year, down 71% from the year before.
NIO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +15.6M shares |
| 1 year | +12% | +267M shares |
| 3 years | +51% | +844M shares |
| 5 years | +60% | +933M shares |
| Available history | +143% | +1.5B shares |
NIO has 2.5B diluted shares, up 12% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
NIO hasn't bought back shares in the past year.
HMC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -3.9x | Net Cash |
| Q1 2026 | 8.6x | High |
| Q4 2025 | 4.9x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | 2.8x | Moderate |
| Q3 2024 | 2.5x | Moderate |
HMC has more cash than debt.
NIO Net Leverage
NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HMC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.4 | Neutral |
| Stochastic | 71.9 | Neutral |
HMC's weekly RSI is 58 (neutral) and its Stochastic is 72 (neutral).
NIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 6.9 | Oversold |
NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
HMC PE vs Consumer Cyclical Sector
| Metric | HMC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
HMC has no meaningful PE right now: it lost money over the past year.
NIO PE vs Consumer Cyclical Sector
NIO has no meaningful PE right now: it lost money over the past year.
HMC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $33.6 | 0.2% below |
| 20 week MA | $31.9 | 5.3% above |
| 50 week MA | $29.4 | 14% above |
| 100 week MA | $29.7 | 13% above |
| 200 week MA | $30.3 | 11% above |
HMC has the edge over NIO on trend strength, trading above more of its moving averages.
NIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 9.2% below |
| 20 week MA | $4.01 | 24% below |
| 50 week MA | $4.81 | 37% below |
| 100 week MA | $4.85 | 37% below |
| 200 week MA | $6.03 | 49% below |
NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.
HMC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.6 | $28.6 | -0.1% |
| 2021 | $28.6 | $28.1 | -1.7% |
| 2022 | $28.1 | $23.1 | -18% |
| 2023 | $23.1 | $30.9 | +34% |
| 2024 | $30.9 | $28.8 | -7% |
| 2025 | $28.8 | $29.8 | +3.6% |
| 2026 YTD | $29.8 | $33.5 | +13% |
HMC has the edge over NIO on returns for 2026, with the stronger performance.
NIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.42 | $45.8 | +1791% |
| 2021 | $45.8 | $30.5 | -33% |
| 2022 | $30.5 | $11.0 | -64% |
| 2023 | $11.0 | $9.07 | -17% |
| 2024 | $9.07 | $4.48 | -51% |
| 2025 | $4.48 | $5.10 | +14% |
| 2026 YTD | $5.10 | $3.05 | -40% |
NIO's yearly returns have swung widely, from +1791% in 2020 to −64% in 2022. It's down 40% so far in 2026.